Eymin B - Search Results

1

A dedicated microarray for in-depth analysis of pre-mRNA splicing events: application to the study of genes involved in the response to targeted anticancer therapies.

Pesson M, Eymin B, De La Grange P, Simon B, Corcos L. Pesson M, et al. Among authors: eymin b. Mol Cancer. 2014 Jan 15;13:9. doi: 10.1186/1476-4598-13-9. Mol Cancer. 2014. PMID: 24428911 Free PMC article.

2

E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35.

Merdzhanova G, Edmond V, De Seranno S, Van den Broeck A, Corcos L, Brambilla C, Brambilla E, Gazzeri S, Eymin B. Merdzhanova G, et al. Among authors: eymin b. Cell Death Differ. 2008 Dec;15(12):1815-23. doi: 10.1038/cdd.2008.135. Epub 2008 Sep 19. Cell Death Differ. 2008. PMID: 18806759 Free article.

3

Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.

Gout S, Brambilla E, Boudria A, Drissi R, Lantuejoul S, Gazzeri S, Eymin B. Gout S, et al. Among authors: eymin b. PLoS One. 2012;7(10):e46539. doi: 10.1371/journal.pone.0046539. Epub 2012 Oct 10. PLoS One. 2012. PMID: 23071587 Free PMC article.

4

RNA splicing, cell signaling, and response to therapies.

Abou Faycal C, Gazzeri S, Eymin B. Abou Faycal C, et al. Among authors: eymin b. Curr Opin Oncol. 2016 Jan;28(1):58-64. doi: 10.1097/CCO.0000000000000254. Curr Opin Oncol. 2016. PMID: 26575690 Free article. Review.

5

A VEGF-A/SOX2/SRSF2 network controls VEGFR1 pre-mRNA alternative splicing in lung carcinoma cells.

Abou Faycal C, Gazzeri S, Eymin B. Abou Faycal C, et al. Among authors: eymin b. Sci Rep. 2019 Jan 23;9(1):336. doi: 10.1038/s41598-018-36728-y. Sci Rep. 2019. PMID: 30674935 Free PMC article.

6

The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo.

Merdzhanova G, Gout S, Keramidas M, Edmond V, Coll JL, Brambilla C, Brambilla E, Gazzeri S, Eymin B. Merdzhanova G, et al. Among authors: eymin b. Oncogene. 2010 Sep 30;29(39):5392-403. doi: 10.1038/onc.2010.281. Epub 2010 Jul 19. Oncogene. 2010. PMID: 20639906

7

Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin.

Edmond V, Moysan E, Khochbin S, Matthias P, Brambilla C, Brambilla E, Gazzeri S, Eymin B. Edmond V, et al. Among authors: eymin b. EMBO J. 2011 Feb 2;30(3):510-23. doi: 10.1038/emboj.2010.333. Epub 2010 Dec 14. EMBO J. 2011. PMID: 21157427 Free PMC article.

8

SRSF2 is required for sodium butyrate-mediated p21(WAF1) induction and premature senescence in human lung carcinoma cell lines.

Edmond V, Brambilla C, Brambilla E, Gazzeri S, Eymin B. Edmond V, et al. Among authors: eymin b. Cell Cycle. 2011 Jun 15;10(12):1968-77. doi: 10.4161/cc.10.12.15825. Epub 2011 Jun 15. Cell Cycle. 2011. PMID: 21555914

9

A new function of the splicing factor SRSF2 in the control of E2F1-mediated cell cycle progression in neuroendocrine lung tumors.

Edmond V, Merdzhanova G, Gout S, Brambilla E, Gazzeri S, Eymin B. Edmond V, et al. Among authors: eymin b. Cell Cycle. 2013 Apr 15;12(8):1267-78. doi: 10.4161/cc.24363. Epub 2013 Mar 21. Cell Cycle. 2013. PMID: 23518498 Free PMC article.

10

Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy.

Abou-Fayçal C, Hatat AS, Gazzeri S, Eymin B. Abou-Fayçal C, et al. Among authors: eymin b. Int J Mol Sci. 2017 Feb 11;18(2):383. doi: 10.3390/ijms18020383. Int J Mol Sci. 2017. PMID: 28208660 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page